NEW YORK, April 16, 2019 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links belowĀ or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC atĀ 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff.Ā Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Vanda Pharmaceuticals Inc. VNDAĀ
Class Period: November 4, 2015 - February 11, 2019
Deadline: April 26, 2019
For more info: www.bgandg.com/vnda
The Complaint alleges that Defendants made materially false and misleading statements and/or failed to disclose that: (1) Vanda was engaged in a fraudulent scheme in which it promoted the off-label use of Fanapt and Hetlioz; (2) the company was fraudulently receiving drug reimbursements from the government by abusing Medicare, Medicaid, and Tricare programs; (3) as a result of the scheme, Vanda faced legal action from the government; (4) Vanda's promotional materials for Fanapt and Hetlioz were false and misleading, garnering regulatory scrutiny from the U.S. Food and Drug Administration; and (5) as a result, defendants' statements about Vanda's business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
Stamps.com Inc. STMPĀ
Class Period: May 3, 2017 - February 21, 2019,
Deadline: April 29, 2019
For more info: www.bgandg.com/stmp
The Complaint alleges that Defendants made materially false and misleading statements and/or failed to disclose that: (1) the Company's financial results depended on the manipulation of a USPS program that cost USPS an estimated $235 million per year; and (2) as a result, the Company's business was unsustainable and its financial results were highly misleading.
Syneos Health, Inc. (NASDAQ: SYNH)
Class Period: May 10, 2017 - February 27, 2019
Deadline: April 30, 2019
For more info: www.bgandg.com/synh
The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that: (1) Syneos Health's internal control over financial reporting was inadequate; (2) concerns regarding Syneos Health's internal control over financial reporting would result in heightened regulatory scrutiny and an SEC investigation into the company's revenue accounting policies, internal controls and related matters; and (3) as a result, defendants' statements about Syneos Health's business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com
Ā© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.